Healthcare Solution Company Carecubes Closes $6.5 Million Series A Funding Round

Carecubes, a healthcare solutions company, has successfully closed a $6.5 million Series A funding round. The funding round was backed by prominent healthcare and public sector leaders including those from Oscar Health, Aetna, Cardinal Health, Medtronic, SEIU, and the University of Nebraska Medical Center. The company's flagship product, the Carecube ISTARI, is an FDA 510(k)-approved isolation unit designed for rapid deployment in healthcare settings.

The Carecube aims to transform infectious disease response by providing exceptional, safe, and compassionate care while isolating pathogens. The company has already seen significant adoption with its Carecube units being purchased by health systems in 36 communities across 13 states and territories, including prominent institutions such as Bellevue Hospital of NYC Health+Hospitals, Providence Sacred Heart Medical Center, and Sacramento County Public Health. Carecubes is led by CEO Alex Laskey and co-founder Saul Griffith, and its Series A investors include leaders from various healthcare organizations and public sector entities.

The company's mission is to eliminate infectious disease transmission in healthcare settings and its innovative approach has garnered support from key industry figures. The Carecube was developed in partnership with the University of Nebraska Medical Center and has received funding and support from entities such as the Defense Advanced Research Projects Agency (DARPA), the Centers for Disease Control and Prevention (CDC), and the Administration for Strategic Preparedness and Response (ASPR). With a focus on scalability and impact, Carecubes aims to address the challenges faced by healthcare systems in managing infectious diseases and protecting patients.

The company's efforts have been praised for delivering affordable and scalable technology to strengthen infectious disease response and improve patient care experiences. The Carecube's ability to facilitate bedside care, minimize PPE use, and enhance patient-provider connections has been highlighted as a significant advancement in infectious disease management. Carecubes' innovative approach and potential for large-scale impact have garnered support from industry leaders, positioning the company as a key player in transforming infectious disease response in healthcare settings.